Tumor necrosis factor alpha—an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?-Reference-Cited by-同舟云学术

Tumor necrosis factor alpha—an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?

Published:2021-09-25 Issue:11 Volume:35 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J Clin Lab Anal

Author:

Mirna Moritz¹^ORCID,Holnthoner Mario¹,Topf Albert¹,Jirak Peter¹,Fejzic Dzeneta¹,Paar Vera¹,Kellermair Jörg²,Blessberger Hermann²,Reiter Christian²,Kammler Jürgen²³,Motloch Lukas J.¹,Jung Christian⁴,Kretzschmar Daniel⁵,Franz Marcus⁵,Alushi Brunilda⁶,Lauten Alexander⁶,Hoppe Uta C.¹,Steinwender Clemens²³,Lichtenauer Michael¹

Affiliation:

1. Department of Internal Medicine II Division of Cardiology Paracelsus Medical University of Salzburg Salzburg Austria

2. Department of Cardiology Kepler University Hospital Medical Faculty Johannes Kepler University Linz Linz Austria

3. Paracelsus Medical University of Salzburg Linz Austria

4. Division of Cardiology, Pulmonology, and Vascular Medicine Medical Faculty University Duesseldorf Dusseldorf Germany

5. Department of Cardiology Clinic of Internal Medicine I Universitätsherzzentrum Thüringen Friedrich Schiller University Jena Jena Germany

6. Department of General and Interventional Cardiology and Rhythmology Helios Clinic Erfurt Germany

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.23977

Reference37 articles.

1. The evolving epidemiology of valvular aortic stenosis. The Tromsø Study

2. The transcatheter valve technology pipeline for treatment of adult valvular heart disease

3. Patient selection for TAVI in 2016: should we break through the low-risk barrier?

4. Meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low surgical risk

5. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumour necrosis factor-alpha serum level is an independent predictor of medium-term all-cause mortality after transcatheter aortic valve replacement;Acta Cardiologica;2024-02-07

2. Biomarkers as Prognostic Markers for Aortic Stenosis: A Review;The American Journal of Cardiology;2023-11

3. The Impact of Monocyte to High-Density Lipoprotein Cholesterol Ratio on All-Cause and Cardiovascular Mortality in Patients with Transcatheter Aortic Valve Replacement;Journal of Personalized Medicine;2023-06-13

4. RNA-sequencing Reveals a Gene Expression Signature in Skeletal Muscle of a Mouse Model of Age-associated Postoperative Functional Decline;The Journals of Gerontology: Series A;2022-02-17

5. Prediction of one- and two-year mortality after transcatheter aortic valve implantation: proposal of a fast sum-score system integrating a novel biomarker of cardiac extracellular matrix accumulation and fibrosis;Reviews in Cardiovascular Medicine;2022-02-14